The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis.
暂无分享,去创建一个
M. Price | N. Welton | A. Ades | J. Macleod | K. Soldan | P. Horner | I. Simms | D. Deangelis | K. Turner
[1] A. Menon-Johansson,et al. Sexually transmitted infections in primary care , 2016 .
[2] Thomas House,et al. Four key challenges in infectious disease modelling using data from multiple sources , 2015, Epidemics.
[3] J. Ravel,et al. Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections. , 2014, Vaccine.
[4] E. Adams,et al. Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! , 2014, Current opinion in infectious diseases.
[5] D. De Angelis,et al. Risk of Pelvic Inflammatory Disease Following Chlamydia trachomatis Infection: Analysis of Prospective Studies With a Multistate Model , 2013, American journal of epidemiology.
[6] S. Lensing,et al. Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. , 2013, The Journal of infectious diseases.
[7] D. De Angelis,et al. Incidence of Chlamydia trachomatis infection in women in England: two methods of estimation , 2013, Epidemiology and Infection.
[8] M. Price,et al. Mixture‐of‐exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection , 2013, Statistics in medicine.
[9] C. Robertson,et al. Estimation of the risk of tubal factor infertility associated with genital chlamydial infection in women: a statistical modelling study. , 2013, International journal of epidemiology.
[10] Anne M Johnson,et al. Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study , 2013, Sexually Transmitted Infections.
[11] R. Brunham,et al. Screening and Treating Chlamydia trachomatis Genital Infection to Prevent Pelvic Inflammatory Disease: Interpretation of Findings From Randomized Controlled Trials , 2013, Sexually transmitted diseases.
[12] S. Mehta. Systematic Review of Randomized Trials of Treatment of Male Sexual Partners for Improved Bacteria Vaginosis Outcomes in Women , 2012, Sexually transmitted diseases.
[13] M. Price,et al. How Much Tubal Factor Infertility Is Caused by Chlamydia? Estimates Based on Serological Evidence Corrected for Sensitivity and Specificity , 2012, Sexually transmitted diseases.
[14] N. Low,et al. Describing the Progression From Chlamydia trachomatis and Neisseria gonorrhoeae to Pelvic Inflammatory Disease: Systematic Review of Mathematical Modeling Studies , 2012, Sexually transmitted diseases.
[15] Boris V. Schmid,et al. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation , 2012, BMJ : British Medical Journal.
[16] S. Osser,et al. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. , 2012, American journal of obstetrics and gynecology.
[17] N. Low,et al. Towards more robust estimates of the transmissibility of Chlamydia trachomatis. , 2012, Sexually transmitted diseases.
[18] R. Raine,et al. Chlamydia screening in England: a qualitative study of the narrative behind the policy , 2012, BMC Public Health.
[19] R. Sweet. Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management , 2012, Current Infectious Disease Reports.
[20] M. Golden,et al. Accelerated partner therapy: a promising new partner treatment option , 2012, Sexually Transmitted Infections.
[21] Boris V. Schmid,et al. Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data , 2012, Journal of The Royal Society Interface.
[22] D. Taylor-Robinson,et al. Difficulties experienced in defining the microbial cause of pelvic inflammatory disease , 2012, International journal of STD & AIDS.
[23] David H. Martin,et al. The Microbiota of the Vagina and Its Influence on Women's Health and Disease , 2012, The American journal of the medical sciences.
[24] Paul J. Birrell,et al. Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London , 2011, Proceedings of the National Academy of Sciences.
[25] A Charlett,et al. Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis , 2011, BMJ : British Medical Journal.
[26] K. Dixon. Introduction to Stochastic Modeling , 2011 .
[27] Neff Walker,et al. Mathematical models in the evaluation of health programmes , 2011, The Lancet.
[28] Anne M Johnson,et al. Can we improve partner notification rates through expedited partner therapy in the UK? Findings from an exploratory trial of Accelerated Partner Therapy (APT) , 2022 .
[29] N. Low,et al. Timing of progression from Chlamydia trachomatis infection to pelvic inflammatory disease: a mathematical modelling study , 2011, BMC Infectious Diseases.
[30] J A Land,et al. Chlamydia antibody testing and diagnosing tubal pathology in subfertile women: an individual patient data meta-analysis. , 2011, Human reproduction update.
[31] S. K. Van Den Eeden,et al. Population-based ectopic pregnancy trends, 1993-2007. , 2011, American journal of preventive medicine.
[32] R. Ness,et al. Microbial Correlates of Delayed Care for Pelvic Inflammatory Disease , 2011, Sexually transmitted diseases.
[33] O. N. Gill,et al. Bayesian evidence synthesis for a transmission dynamic model for HIV among men who have sex with men , 2011, Biostatistics.
[34] S. Kerry,et al. What is the cost of pelvic inflammatory disease and how much could be prevented by screening for Chlamydia trachomatis? Cost analysis of the Prevention Of Pelvic Infection (POPI) trial , 2011, Sexually Transmitted Infections.
[35] K. Soldan,et al. Estimation of the Rate of Pelvic Inflammatory Disease Diagnoses: Trends in England, 2000–2008 , 2011, Sexually transmitted diseases.
[36] S. Berman,et al. Danish health register study: a randomised trial with findings about the implementation of chlamydia screening, but not about its benefits , 2011, Sexually Transmitted Infections.
[37] T. Uppal,et al. Chronic pelvic pain , 2011, Australasian journal of ultrasound in medicine.
[38] Malcolm J Price,et al. Parameterization of treatment effects for meta‐analysis in multi‐state Markov models , 2011, Statistics in medicine.
[39] Katy Turner,et al. Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study , 2011, BMJ : British Medical Journal.
[40] O. Dueñas-Garcia. Pelvic inflammatory disease. , 2010 .
[41] A. Presanis,et al. Insights into the rise in HIV infections, 2001 to 2008: a Bayesian synthesis of prevalence evidence , 2010, AIDS.
[42] F. Olesen,et al. Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up , 2010, Sexually Transmitted Infections.
[43] Catherine H Mercer,et al. Management of first-episode pelvic inflammatory disease in primary care: results from a large UK primary care database. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.
[44] N. Low,et al. Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. , 2010, Epidemics.
[45] G. Scott,et al. Expedited partner therapy for Chlamydia trachomatis at the community pharmacy , 2010, BJOG : an international journal of obstetrics and gynaecology.
[46] K. Holmes,et al. Expedited Partner Therapy: A Robust Intervention , 2010, Sexually transmitted diseases.
[47] N. Low,et al. Risk of sequelae after Chlamydia trachomatis genital infection in women. , 2010, The Journal of infectious diseases.
[48] Robert E. Johnson,et al. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. , 2010, The Journal of infectious diseases.
[49] N. Low,et al. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? , 2010, The Journal of infectious diseases.
[50] R. Brunham,et al. Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. , 2010, The Journal of infectious diseases.
[51] W. Geisler. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. , 2010, The Journal of infectious diseases.
[52] T. Darville,et al. Pathogenesis of genital tract disease due to Chlamydia trachomatis. , 2010, The Journal of infectious diseases.
[53] Julie Glanville,et al. Searching for Evidence for Cost‐Effectiveness Decisions , 2010 .
[54] S. Kerry,et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial , 2010, BMJ : British Medical Journal.
[55] C. Hoebe,et al. Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis , 2010, BMC infectious diseases.
[56] S Dias,et al. Checking consistency in mixed treatment comparison meta‐analysis , 2010, Statistics in medicine.
[57] M. Postma,et al. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. , 2010, Human reproduction update.
[58] C. Kent,et al. Trends in the Diagnosis and Treatment of Ectopic Pregnancy in the United States , 2010, Obstetrics and gynecology.
[59] J. Kurinczuk,et al. The epidemiology of infertility in the North East of Scotland. , 2009, Human reproduction.
[60] B. Thomas,et al. Further observations, mainly serological, on a cohort of women with or without pelvic inflammatory disease , 2009, International journal of STD & AIDS.
[61] I. Bakken,et al. Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study , 2009, BMC infectious diseases.
[62] M. Kretzschmar,et al. Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study , 2009, Sexually Transmitted Infections.
[63] Anne M Johnson,et al. Pgp3 Antibody Enzyme-Linked Immunosorbent Assay, a Sensitive and Specific Assay for Seroepidemiological Analysis of Chlamydia trachomatis Infection , 2009, Clinical and Vaccine Immunology.
[64] N. Low,et al. Real-Time Quantitative PCR To Determine Chlamydial Load in Men and Women in a Community Setting , 2009, Journal of Clinical Microbiology.
[65] N. Low,et al. Effectiveness of chlamydia screening: systematic review. , 2009, International journal of epidemiology.
[66] R. Elton,et al. Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial. , 2009, Human reproduction.
[67] S. Kerry,et al. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial , 2008, Trials.
[68] Nicky J Welton,et al. Multiparameter evidence synthesis in epidemiology and medical decision-making , 2008, Journal of health services research & policy.
[69] S. Morrison,et al. Absence of lymphogranuloma venereum strains among rectal Chlamydia trachomatis outer membrane protein A genotypes infecting women and men who have sex with men in Birmingham, Alabama. , 2008, Sexually transmitted diseases.
[70] A E Ades,et al. Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit. , 2008, Biostatistics.
[71] Catherine H Mercer,et al. Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data , 2008 .
[72] F. Cecinato,et al. Chlamydia trachomatis detection in a population of asymptomatic and symptomatic women: correlation with the presence of serological markers for this infection. , 2008, The new microbiologica.
[73] P. Horner,et al. Has the incidence of pelvic inflammatory disease following chlamydial infection been overestimated? , 2008, International journal of STD & AIDS.
[74] S. Bhattacharya,et al. Effect of female age on the diagnostic categories of infertility. , 2008, Human reproduction.
[75] Julian P T Higgins,et al. Recent developments in meta‐analysis , 2008, Statistics in medicine.
[76] Anne M Johnson,et al. A new role for Chlamydia trachomatis serology? , 2008, Sexually Transmitted Infections.
[77] C. Black,et al. The Natural History of Untreated Chlamydia trachomatis Infection in the Interval Between Screening and Returning for Treatment , 2008, Sexually Transmitted Diseases.
[78] J. Peipert,et al. Chlamydia Antibodies, Chlamydia Heat Shock Protein, and Adverse Sequelae After Pelvic Inflammatory Disease: The PID Evaluation and Clinical Health (PEACH) Study , 2008, Sexually transmitted diseases.
[79] L. Oakley,et al. Lifetime prevalence of infertility and infertility treatment in the UK: results from a population-based survey of reproduction. , 2007, Human reproduction.
[80] M. Reid,et al. What is the excess risk of infertility in women after genital chlamydia infection? A systematic review of the evidence , 2007, Sexually Transmitted Infections.
[81] J. Kendrick,et al. The Prevalence of Bacterial Vaginosis in the United States, 2001–2004; Associations With Symptoms, Sexual Behaviors, and Reproductive Health , 2007, Sexually transmitted diseases.
[82] W. Risser,et al. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review , 2007, International journal of STD & AIDS.
[83] S. M. Rogers,et al. Concordance of chlamydia trachomatis infections within sexual partnerships , 2007, Sexually Transmitted Infections.
[84] Nicky J Welton,et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses , 2007, BMJ : British Medical Journal.
[85] N. Low,et al. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project , 2007, BMJ : British Medical Journal.
[86] W. Edmunds,et al. The cost effectiveness of opportunistic chlamydia screening in England , 2007, Sexually Transmitted Infections.
[87] S. Lydersen,et al. Births and Ectopic Pregnancies in a Large Cohort of Women Tested for Chlamydia trachomatis , 2007, Sexually transmitted diseases.
[88] N. Low. Screening programmes for chlamydial infection: when will we ever learn? , 2007, BMJ : British Medical Journal.
[89] D. Eschenbach. Treatment of pelvic inflammatory disease. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[90] Helen H. Lee,et al. Chlamydia trachomatis Load at Matched Anatomic Sites: Implications for Screening Strategies , 2007, Journal of Clinical Microbiology.
[91] I. Bakken,et al. Chlamydia Trachomatis Infections Increase the Risk for Ectopic Pregnancy: A Population-Based, Nested Case–Control Study , 2007, Sexually transmitted diseases.
[92] J. Sterne,et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. , 2007, Health technology assessment.
[93] J. Peipert,et al. Prevalence of Bacterial Vaginosis: 2001–2004 National Health and Nutrition Examination Survey Data , 2007, Obstetrics and gynecology.
[94] W. Edmunds,et al. Modelling the effectiveness of chlamydia screening in England , 2006, Sexually Transmitted Infections.
[95] S. Rasmussen,et al. Emerging Infections and Pregnancy , 2006, Emerging infectious diseases.
[96] A. Davies,et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group , 2006, Sexually Transmitted Infections.
[97] Jun Cai,et al. Mixtures of Exponential Distributions , 2006 .
[98] J. Stephenson,et al. Risk factors associated with pelvic inflammatory disease , 2006, Sexually Transmitted Infections.
[99] S. Goldie,et al. The Impact of Natural History Parameters on the Cost-Effectiveness of Chlamydia trachomatis Screening Strategies , 2006, Sexually transmitted diseases.
[100] J. Sterne,et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women’s Cohort Study , 2006, Sexually Transmitted Infections.
[101] W John Edmunds,et al. Developing a realistic sexual network model of chlamydia transmission in Britain , 2006, Theoretical Biology and Medical Modelling.
[102] Alex J. Sutton,et al. Multiparameter evidence synthesis in epidemiology and medical decision‐making: current approaches , 2006 .
[103] William D Mosher,et al. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. , 2005, Vital and health statistics. Series 23, Data from the National Survey of Family Growth.
[104] N. Welton,et al. Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.
[105] Mirjam Kretzschmar,et al. Costs and Effects of Chlamydial Screening: Dynamic versus Static Modeling , 2005, Sexually transmitted diseases.
[106] Ali Esmaili,et al. Probability and Random Processes , 2005, Technometrics.
[107] Anne M Johnson,et al. Chlamydia trachomatis Testing in the Second British National Survey of Sexual Attitudes and Lifestyles: Respondent Uptake and Treatment Outcomes , 2005, Sexually transmitted diseases.
[108] H. Schønheyder,et al. Ectopic Pregnancies and Reproductive Capacity After Chlamydia trachomatis Positive and Negative Test Results: A Historical Follow-Up Study , 2005, Sexually transmitted diseases.
[109] A. Boeke,et al. De kans op 'pelvic inflammatory disease' bij urogenitale infectie met Chlamydia trachomatis; literatuuronderzoek , 2005 .
[110] J. Sterne,et al. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study , 2005, BMJ : British Medical Journal.
[111] S. Franceschi,et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. , 2005, The Journal of infectious diseases.
[112] B. Sibai,et al. Spontaneous Resolution of Asymptomatic Chlamydia trachomatis in Pregnancy , 2005, Obstetrics and gynecology.
[113] K. Holmes,et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. , 2005, The New England journal of medicine.
[114] R. Brunham,et al. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.
[115] S. Goldie,et al. Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis , 2004, Annals of Internal Medicine.
[116] W. Edmunds,et al. Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies , 2004, Sexually Transmitted Infections.
[117] Lex M Bouter,et al. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses. , 2004, International journal of epidemiology.
[118] P. Mårdh. Tubal factor infertility, with special regard to chlamydial salpingitis , 2004, Current opinion in infectious diseases.
[119] D. Dunson,et al. Increased Infertility With Age in Men and Women , 2004, Obstetrics and gynecology.
[120] C. Bruggeman,et al. Performance of five serological chlamydia antibody tests in subfertile women. , 2003, Human reproduction.
[121] F. Warburton,et al. Diagnosis of pelvic inflammatory disease: time for a rethink , 2003, Sexually transmitted infections.
[122] P. Heinonen,et al. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole , 2003, Archives of Gynecology and Obstetrics.
[123] D. Cahill,et al. Tubal damage in infertile women: prediction using chlamydia serology. , 2003, Human reproduction.
[124] K. Thomas,et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease , 2003, Journal of clinical pathology.
[125] J. Coste,et al. Risk factors for ectopic pregnancy: a comprehensive analysis based on a large case-control, population-based study in France. , 2003, American journal of epidemiology.
[126] D. Veenstra,et al. The Clinical and Economic Consequences of Screening Young Men for Genital Chlamydial Infection , 2003, Sexually transmitted diseases.
[127] S. Morré,et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up , 2002, International journal of STD & AIDS.
[128] J. Paavonen,et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. , 2002, Journal of medical microbiology.
[129] L. Wang,et al. An Economic Evaluation of a School-Based Sexually Transmitted Disease Screening Program , 2002, Sexually transmitted diseases.
[130] Kenneth M Persson,et al. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections. , 2002, Best practice & research. Clinical obstetrics & gynaecology.
[131] Bradley P. Carlin,et al. Bayesian measures of model complexity and fit , 2002 .
[132] L. Bouter,et al. Follow-up, treatment, and reinfection rates among asymptomatic chlamydia trachomatis cases in general practice. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.
[133] A E Ades,et al. Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.
[134] J. Hopwood,et al. Resolution of the recent performance problem of Abbott LCx Chlamydia trachomatis assay. Issues of repeat testing for confirmation of chlamydial infection , 2002, Sexually transmitted infections.
[135] J. Lave,et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. , 2002, American journal of obstetrics and gynecology.
[136] J. Douglas,et al. Persistence of Chlamydia trachomatis Infection Detected by Polymerase Chain Reaction in Untreated Patients , 2002, Sexually transmitted diseases.
[137] W. Cates,et al. Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach? , 2002, Sexually transmitted diseases.
[138] Christian Munk,et al. Comparison of Three Commercially Available Peptide-Based Immunoglobulin G (IgG) and IgA Assays to Microimmunofluorescence Assay for Detection of Chlamydia trachomatis Antibodies , 2002, Journal of Clinical Microbiology.
[139] M. R. Howell,et al. Cost-Effectiveness of Five Strategies for Gonorrhea and Chlamydia Control Among Female and Male Emergency Department Patients , 2002, Sexually transmitted diseases.
[140] Ronald H Gray,et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? , 2002, International journal of STD & AIDS.
[141] Anne M Johnson,et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection , 2001, The Lancet.
[142] R. Goeree,et al. Cost-Effectiveness of Screening Swab or Urine Specimens for Chlamydia trachomatis From Young Canadian Women in Ontario , 2001, Sexually transmitted diseases.
[143] W. Whittington,et al. Quantitative culture of Chlamydia trachomatis: relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. , 2001, The Journal of infectious diseases.
[144] J. Peipert,et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. , 2001, American journal of obstetrics and gynecology.
[145] M. Helfand,et al. Screening for chlamydial infection. , 2001, American journal of preventive medicine.
[146] A. Raftery,et al. Inference for Deterministic Simulation Models: The Bayesian Melding Approach , 2000 .
[147] Geoffrey J. McLachlan,et al. Finite Mixture Models , 2019, Annual Review of Statistics and Its Application.
[148] F. Olesen,et al. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[149] J C Jager,et al. Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. , 2000, Sexually transmitted diseases.
[150] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[151] D. Grimes. Intrauterine device and upper-genital-tract infection , 2000, The Lancet.
[152] A. Herring,et al. Screening for chlamydia , 2000, Communicable disease and public health.
[153] M. Golden,et al. Duration of Untreated Genital Infections With Chlamydia trachomatis: A Review of the Literature , 2000, Sexually transmitted diseases.
[154] J R P Townshend,et al. Analysing the effectiveness of Chlamydia screening , 2000, J. Oper. Res. Soc..
[155] F Dominici,et al. Combining Contingency Tables with Missing Dimensions , 2000, Biometrics.
[156] J. Stephenson,et al. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? , 2000, Sexually transmitted infections.
[157] A Hadgu,et al. Discrepant analysis: a biased and an unscientific method for estimating test sensitivity and specificity. , 1999, Journal of clinical epidemiology.
[158] S. Ramsey,et al. Weighing the Economic Evidence: Guidelines for Critical Assessment of Cost-Effectiveness Analyses , 1999, The Journal of the American Board of Family Medicine.
[159] J. Schwebke,et al. Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center. , 1999, Sexually transmitted diseases.
[160] J. Paavonen,et al. Chlamydia trachomatis: impact on human reproduction. , 1999, Human reproduction update.
[161] H. Brade,et al. Antibodies to Chlamydia trachomatis heat shock proteins in women with tubal factor infertility are associated with prior infection by C. trachomatis but not by C. pneumoniae. , 1999, Human reproduction.
[162] Andrew Gelman,et al. General methods for monitoring convergence of iterative simulations , 1998 .
[163] N. Low,et al. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. , 1998, BMJ.
[164] J. Lave,et al. Design of the PID Evaluation and Clinical Health (PEACH) Study. , 1998, Controlled clinical trials.
[165] C. Black,et al. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. , 1998, Clinical microbiology reviews.
[166] W. Miller,et al. Bias in discrepant analysis: when two wrongs don't make a right. , 1998, Journal of clinical epidemiology.
[167] Arthur P. Dempster,et al. The direct use of likelihood for significance testing , 1997, Stat. Comput..
[168] R. Wolpert,et al. Combining Information From Related Regressions , 1997 .
[169] A. Nicoll,et al. The influence of demographic change and cumulative risk of pelvic inflammatory disease on the incidence of ectopic pregnancy , 1997, Epidemiology and Infection.
[170] P. Bossuyt,et al. The accuracy of serum chlamydial antibodies in the diagnosis of tubal pathology: a meta-analysis. , 1997, Fertility and sterility.
[171] E. Hook,et al. Spontaneous Clearance of Chlamydia trachomatis Infection in Untreated Patients , 1997, Sexually transmitted diseases.
[172] J. Peipert,et al. Oral contraception and the recognition of endometritis. , 1997, American journal of obstetrics and gynecology.
[173] Perez Ja,et al. Screening for chlamydia to prevent pelvic inflammatory disease. , 1996 .
[174] M. Kretzschmar,et al. Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. , 1996, American journal of epidemiology.
[175] P. Bossuyt,et al. Risk factors for ectopic pregnancy: a meta-analysis. , 1996, Fertility and sterility.
[176] K. Holmes,et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. , 1996, The New England journal of medicine.
[177] G. Guyatt,et al. Users' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations , 1995 .
[178] Mitchell J. Small,et al. Updating Uncertainty in an Integrated Risk Assessment: Conceptual Framework and Methods , 1995 .
[179] L. Westrom. Effect of pelvic inflammatory disease on fertility. , 1995, Venereology : official publication of the National Venereology Council of Australia.
[180] P. Wølner-Hanssen,et al. Silent pelvic inflammatory disease: is it overstated? , 1995, Obstetrics and gynecology.
[181] Adrian E. Raftery,et al. Inference from a Deterministic Population Dynamics Model for Bowhead Whales , 1995 .
[182] G. Ridgway,et al. Clinical, laparoscopic and microbiological findings in acute salpingitis: report on a United Kingdom cohort , 1995, British journal of obstetrics and gynaecology.
[183] V Hasselblad,et al. Meta-analytic Tools for Medical Decision Making: A Practical Guide , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.
[184] T. Quinn,et al. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. , 1994, JAMA.
[185] R. Hanka. The Handbook of Research Synthesis , 1994 .
[186] B. Laumon,et al. Sexually transmitted diseases as major causes of ectopic pregnancy: results from a large case-control study in France. , 1994, Fertility and sterility.
[187] J. L. Sørensen,et al. Early- and late-onset pelvic inflammatory disease among women with cervicalChlamydia trachomatis infection at the time of induced abortion — A follow-up study , 1994 .
[188] J. Coste,et al. Incidence of ectopic pregnancy. First results of a population-based register in France. , 1994, Human reproduction.
[189] D. Gunnell,et al. Infertility prevalence, needs assessment and purchasing. , 1994, Journal of public health medicine.
[190] W. Cates,et al. Atypical pelvic inflammatory disease: can we identify clinical predictors? , 1993, American journal of obstetrics and gynecology.
[191] M. Goldacre,et al. Morbidity following pelvic inflammatory disease , 1993, British journal of obstetrics and gynaecology.
[192] W. Cates,et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility , 1993, American journal of obstetrics and gynecology.
[193] S. Thompson,et al. Pelvic Inflammatory Disease and Fertility: A Cohort Study of 1,844 Women with Laparoscopically Verified Disease and 657 Control Women with Normal Laparoscopic Results , 1992, Sexually transmitted diseases.
[194] R. Sweet,et al. Long-term sequelae of acute pelvic inflammatory disease. A retrospective cohort study. , 1992, American journal of obstetrics and gynecology.
[195] T. Farley,et al. Intrauterine devices and pelvic inflammatory disease: an international perspective , 1992, The Lancet.
[196] W. Cates,et al. Genital chlamydial infections: epidemiology and reproductive sequelae. , 1991, American journal of obstetrics and gynecology.
[197] S. Cox,et al. A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. , 1991, American journal of obstetrics and gynecology.
[198] T. Tsukagoshi. [Epidemiological study on Chlamydia trachomatis infection among sexually active female adolescents]. , 1990, Nihon Sanka Fujinka Gakkai zasshi.
[199] A. Templeton,et al. The epidemiology of infertility in Aberdeen. , 1990, BMJ.
[200] G. Rydén,et al. Antibodies to Chlamydia trachomatis in women with infertility, pelvic inflammatory disease and ectopic pregnancy. , 1990, European journal of obstetrics, gynecology, and reproductive biology.
[201] C. Nord,et al. Second look laparoscopy; evaluation of two different antibiotic regimens after treatment of acute salpingitis. , 1989, European journal of obstetrics, gynecology, and reproductive biology.
[202] K. Persson,et al. Tubal infertility and silent chlamydial salpingitis. , 1989, Human reproduction.
[203] J. Sellors,et al. Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis. , 1988, Fertility and sterility.
[204] O. Lunde,et al. Infertility and chlamydial infection , 1987, Fertility and sterility.
[205] W. Kennedy,et al. Acute pelvic inflammatory disease: a clinical follow-up. , 1987, International journal of fertility.
[206] C. Nord,et al. Salpingitis; aspects of diagnosis and etiology: a 4-year study from a Swedish capital hospital. , 1987, European journal of obstetrics, gynecology, and reproductive biology.
[207] J. Paavonen,et al. Second Laparoscopy After Treatment of Acute Pelvic Inflammatory Disease , 1987, Obstetrics and gynecology.
[208] R. Brunham,et al. Fallopian tube obstruction as a sequela toChlamydia trachomatis infection , 1986, European Journal of Clinical Microbiology.
[209] D. Conway,et al. Population study of causes, treatment, and outcome of infertility. , 1985, British medical journal.
[210] Donald Geman,et al. Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images , 1984, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[211] K. Holmes,et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. , 1984, The New England journal of medicine.
[212] J. Hodgson,et al. CHLAMYDIAL SEROLOGY IN FERTILE AND INFERTILE WOMEN , 1984, The Lancet.
[213] P. Wølner-Hanssen,et al. Second-look laparoscopy after acute salpingitis. , 1983, Obstetrics and gynecology.
[214] L. Westergaard,et al. Significance of Cervical Chlamydia trachomatis Infection in Postabortal Pelvic Inflammatory Disease , 1982, Obstetrics and gynecology.
[215] W. Chavkin. The rise in ectopic pregnancy ‐ exploration of possible reasons , 1982, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[216] H. Akaike. Likelihood of a model and information criteria , 1981 .
[217] P. Mårdh,et al. Incidence, trends, and risks of ectopic pregnancy in a population of women. , 1981, British medical journal.
[218] P. Mårdh,et al. Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serologic findings. , 1980, American journal of obstetrics and gynecology.
[219] E. Lycke,et al. Genital Chlamydia trachomatis Infection in Women , 1980, Obstetrics and gynecology.
[220] L Weström,et al. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. , 1980, American journal of obstetrics and gynecology.
[221] P. Saikku,et al. Treatment of nongonococcal urethritis with trimethoprim-sulphadiazine and with placebo. A double-blind partner-controlled study. , 1980, The British journal of venereal diseases.
[222] P. Wølner-Hanssen,et al. Pathogenesis of pelvic inflammatory disease. , 1979, British medical journal.
[223] P. Mårdh,et al. Antibodies to Chlamydia trachomatis in acute salpingitis. , 1979, The British journal of venereal diseases.
[224] W M McCormack,et al. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. , 1979, The New England journal of medicine.
[225] S. Cohen,et al. Are chlamydial infections the most prevalent venereal disease? , 1975, JAMA.
[226] K. Holmes,et al. Polymicrobial etiology of acute pelvic inflammatory disease. , 1975, The New England journal of medicine.
[227] W. K. Hastings,et al. Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .
[228] Marvin Zelen,et al. On the theory of screening for chronic diseases , 1969 .
[229] M. E. Davis. Management of infertility. , 1967, JAMA.
[230] W. Bond. Probable Values of e, h, e/m and α. A Reply to R. T. Birge , 1932 .
[231] R. T. Birge. Probable Values of e, h, em, and α , 1932 .
[232] N. Bingham,et al. Generalised Linear Models , 2010 .
[233] S. Kelsey,et al. Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[234] Peter Pirolli,et al. Information Foraging , 2009, Encyclopedia of Database Systems.
[235] S. Morré,et al. [The risk of pelvic inflammatory disease associated with urogenital infection with Chlamydia trachomatis; literature review]. , 2005, Nederlands tijdschrift voor geneeskunde.
[236] M. A. Best. Bayesian Approaches to Clinical Trials and Health‐Care Evaluation , 2005 .
[237] J. Ross. Pelvic inflammatory disease. , 2005, Clinical evidence.
[238] M. Kretzschmar,et al. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. , 2001, American journal of epidemiology.
[239] Nils Lid Hjort,et al. Model Selection and Model Averaging , 2001 .
[240] National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). , 1999, Sexually Transmitted Infections.
[241] D. Eschenbach,et al. Infertility following pelvic inflammatory disease. , 1999, Infectious diseases in obstetrics and gynecology.
[242] C. Weinberg,et al. Use and misuse of population attributable fractions. , 1998, American journal of public health.
[243] J. Stephenson. Screening for genital chlamydial infection. , 1998, British Medical Bulletin.
[244] W. M. Mac Kenzie,et al. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. , 1997, American journal of obstetrics and gynecology.
[245] A. Närvänen,et al. Detection of Antibodies to Chlamydia trachomatis With Peptide-Based Species-Specific Enzyme Immunoassay , 1997, Infectious diseases in obstetrics and gynecology.
[246] B. Gerber,et al. A study of second-look laparoscopy after acute salpingitis , 1996, Archives of Gynecology and Obstetrics.
[247] E. Arsura,et al. Screening for chlamydia to prevent pelvic inflammatory disease. , 1996, New England Journal of Medicine.
[248] L. Weström. Sexually transmitted diseases and infertility. , 1994, Sexually transmitted diseases.
[249] David M. Eddy,et al. Meta-analysis by the confidence profile method , 1992 .
[250] C. Goldsmith,et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. , 1991, American journal of obstetrics and gynecology.
[251] R. Sweet,et al. Criteria for diagnosis and grading of salpingitis. , 1983, Obstetrics and gynecology.
[252] L. Weström. Effect of acute pelvic inflammatory disease on fertility. , 1975, American journal of obstetrics and gynecology.
[253] M. Graffar. [Modern epidemiology]. , 1971, Bruxelles medical.
[254] Ja Wilson,et al. Principles and practice of screening for disease , 1968 .
[255] D. M. Green,et al. Signal detection theory and psychophysics , 1966 .